Search results - 16 results
Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis.
1, 2022. Inclusion criteria were population-based surveys in men aged 15 years or older or HPV prevalence studies with a sample size of at least 50 men with no HPV-related pathology or known risk ...
Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework.
detection and separate identification of 14 hrHPV types. Here, we present the clinical validation of the test in SurePath samples in comparison to a clinically validated reference test, the GP5 +/6+Enzyme ...
Assessment of the clinical and analytical performance of the Aptima SARS-CoV-2 assay using the VALCOR protocol.
a study protocol designed to set up a framework for test validation of SARS-CoV-2 virus assays. Using clinical samples collated from VALCOR, the performance of Aptima SARS-CoV-2 assay was assessed against ...
Acceptability to Healthcare Professionals of Home-Based HPV Self-Sampling for Cervical Screening: A French Qualitative Study Conducted in an Area with Low Access to Health Services
underscreened women urine self-sampling vaginal self-sampling Abstract: Self-sampling may improve participation in cervical cancer secondary prevention programs by women who do not respond or respond irregularly ...
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework.
of 13 high-risk (hr) HPV s. OncoPredict HPV ® SCR (index assay) identifies HPV-16 and HPV-18 separately, 11 other hrHPV in aggregate and includes quality controls for sample adequacy, DNA extraction ...
Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening
HPV SCREENING self-sampling self-sampling kits Abstract: BACKGROUND: Human papillomavirus (HPV) testing on self-samples represents a great opportunity to increase cervical cancer screening uptake among ...
The European response to the WHO call cervical cancer as a public health problem
achieve 70% of screening coverage in the target age group, providing also HPV testing on self‐samples for non‐ or under‐screened women; and to manage 90% of screen‐positive women. To guide member states, ...
Tackling cervical cancer in Europe amidst the COVID-19 pandemic.
applied on self-collected samples, a strategy that might be used to reach underscreened populations. In May, 2018, the WHO Director General launched a call to eliminate cervical cancer by vaccinating at ...
Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study.
Baseline liquid-based cytology samples were tested for HPV. Conditional logistic regression analysis was used to calculate odds ratios (OR s) with confidence intervals (CI s). RESULTS The risk of future ...
Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.
Publication Type: Peer reviewed scientific article Authors: M. Arbyn; Smith, Sara B; Temin, Sarah; Sultana, Farhana; Castle, Philip; Collaboration on Self-Sampling and HPV Testing Source: BMJ, ...